Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have been assigned an average recommendation of “Hold” from the seventeen research firms that are covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, six have given a hold rating and eight have issued a buy rating on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $44.91.
A number of equities research analysts have recently weighed in on the stock. Cantor Fitzgerald cut their target price on shares of Acadia Healthcare from $48.00 to $39.00 and set a “neutral” rating on the stock in a research note on Tuesday, October 24th. Craig Hallum reaffirmed a “buy” rating and set a $41.00 target price (down previously from $65.00) on shares of Acadia Healthcare in a research note on Thursday, October 26th. Zacks Investment Research lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, October 2nd. Jefferies Group set a $42.00 target price on shares of Acadia Healthcare and gave the company a “buy” rating in a research note on Wednesday, October 25th. Finally, Bank of America cut their target price on shares of Acadia Healthcare from $60.00 to $52.00 and set a “buy” rating on the stock in a research note on Wednesday, October 25th.
Acadia Healthcare (NASDAQ:ACHC) opened at $34.01 on Friday. The stock has a market cap of $2,918.50, a PE ratio of 17.26, a price-to-earnings-growth ratio of 1.13 and a beta of 0.90. The company has a debt-to-equity ratio of 1.30, a current ratio of 1.36 and a quick ratio of 1.36. Acadia Healthcare has a 52-week low of $26.92 and a 52-week high of $54.34.
In related news, Director Reeve B. Waud sold 100,000 shares of the business’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $31.80, for a total transaction of $3,180,000.00. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 11.10% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the company. State of Alaska Department of Revenue bought a new position in shares of Acadia Healthcare in the fourth quarter worth approximately $150,000. C M Bidwell & Associates Ltd. bought a new position in shares of Acadia Healthcare in the second quarter worth approximately $205,000. Riverhead Capital Management LLC bought a new position in shares of Acadia Healthcare in the second quarter worth approximately $209,000. Rathbone Brothers plc bought a new position in shares of Acadia Healthcare in the third quarter worth approximately $223,000. Finally, Arthur Zaske & Associates LLC bought a new position in shares of Acadia Healthcare in the third quarter worth approximately $283,000.
COPYRIGHT VIOLATION NOTICE: “Acadia Healthcare Company, Inc. (ACHC) Given Average Recommendation of “Hold” by Analysts” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this article on another website, it was stolen and republished in violation of U.S. and international copyright & trademark law. The legal version of this article can be viewed at https://www.americanbankingnews.com/2018/01/20/acadia-healthcare-company-inc-achc-given-average-recommendation-of-hold-by-analysts.html.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.